Skip to main content
PMC home page
Springer logoLink to Springer
. 2014 Nov 25;262(1):248. doi: 10.1007/s00415-014-7565-7

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

Tjalf Ziemssen 1,✉, Ovidiu A Bajenaru 2, Adriana Carrá 3, Nina de Klippel 4, João Correia de Sá 5, Astrid Edland 6, Jette L Frederiksen 7, Olivier Heinzlef 8, Klimentini E Karageorgiou 9, Rafael H Lander Delgado, Anne-Marie Landtblom 10,11, Miguel A Macías Islas 12, Niall Tubridy 13, Yossi Gilgun-Sherki 14
PMCID: PMC4643571  PMID: 25417969

Erratum to: J Neurol (2014) 261:2101–2111 DOI 10.1007/s00415-014-7446-0

The original version of this article unfortunately contained a mistake. The affiliation of the fifth author (João Correia de Sá) is incorrect. The correct affiliation should be:

J. Correia de Sá

Hospital de Santa Maria, Lisbon, Portugal

Footnotes

The online version of the original article can be found under doi:10.1007/s00415-014-7446-0.

Articles from Journal of Neurology are provided here courtesy of Springer

RESOURCES